Gibbons MB, Wilcox KS.
Could Astrocytes Be Used to Beat Epilepsy? Experiments in dnSNARE Mice Drum Up New Hope.
Epilepsy Curr. 2014 Sep;14(5):277-8. doi: 10.5698/1535-7597-14.5.277. No abstract available.


Gee JM, Smith NA, Fernandez FR, Economo MN, Brunert D, Rothermel M, Morris SC, Talbot A, Palumbos S, Ichida JM, Shepherd JD, West PJ, Wachowiak M, Capecchi MR, Wilcox KS, White JA, Tvrdik P.
Imaging activity in neurons and glia with a Polr2a-based and cre-dependent GCaMP5G-IRES-tdTomato reporter mouse.
Neuron. 2014 Sep 3;83(5):1058-72. doi: 10.1016/j.neuron.2014.07.024. Epub 2014 Aug 21.


Simonato M, Brooks-Kayal AR, Engel J Jr, Galanopoulou AS, Jensen FE, Moshé SL, O'Brien TJ, Pitkanen A, Wilcox KS, French JA.
The challenge and promise of anti-epileptic therapy development in animal models.
Lancet Neurol. 2014 Sep;13(9):949-60. doi: 10.1016/S1474-4422(14)70076-6. Epub 2014 Aug 10. Review.


Wilcox KS, Vezzani A.
Does brain inflammation mediate pathological outcomes in epilepsy?
Adv Exp Med Biol. 2014;813:169-83. doi: 10.1007/978-94-017-8914-1_14. Review.


Vargas JR, Takahashi DK, Thomson KE, Wilcox KS.
The expression of kainate receptor subunits in hippocampal astrocytes after experimentally induced status epilepticus.
J Neuropathol Exp Neurol. 2013 Oct;72(10):919-32. doi: 10.1097/NEN.0b013e3182a4b266.


Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C.
Current understanding of the mechanism of action of the antiepileptic drug lacosamide.
Epilepsy Res. 2015 Feb;110C:189-205. doi: 10.1016/j.eplepsyres.2014.11.021. Epub 2014 Dec 3. Review.


Barker-Haliski M, Friedman D, White HS, French JA.
How clinical development can, and should, inform translational science.
Neuron. 2014 Nov 5;84(3):582-93. doi: 10.1016/j.neuron.2014.10.029. Epub 2014 Nov 5. Review.


Metcalf CS, Klein BD, McDougle DR, Zhang L, Smith MD, Bulaj G, White HS.
Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models.
J Pharmacol Exp Ther. 2015 Jan;352(1):185-93. doi: 10.1124/jpet.114.219063. Epub 2014 Oct 27.


Thomson KE, White HS.
A novel open-source drug-delivery system that allows for first-of-kind simulation of nonadherence to pharmacological interventions in animal disease models.
J Neurosci Methods. 2014 Dec 30;238:105-11. doi: 10.1016/j.jneumeth.2014.09.019. Epub 2014 Sep 26.


Barker-Haliski M, Sills GJ, White HS.
What are the arguments for and against rational therapy for epilepsy?
Adv Exp Med Biol. 2014;813:295-308. doi: 10.1007/978-94-017-8914-1_24. Review.


Schousboe A, Madsen KK, Barker-Haliski ML, White HS.
The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters.
Neurochem Res. 2014 Oct;39(10):1980-7. doi: 10.1007/s11064-014-1263-9. Epub 2014 Mar 14.


West PJ, Saunders GW, Remigio GJ, Wilcox KS, White HS.
Antiseizure drugs differentially modulate θ-burst induced long-term potentiation in C57BL/6 mice.
Epilepsia. 2014 Feb;55(2):214-23. doi: 10.1111/epi.12524. Epub 2014 Jan 21.


White HS, Löscher W.
Searching for the ideal antiepileptogenic agent in experimental models: single treatment versus combinatorial treatment strategies.
Neurotherapeutics. 2014 Apr;11(2):373-84. doi: 10.1007/s13311-013-0250-1. Review.


Umpierre AD, Remigio GJ, Dahle EJ, Bradford K, Alex AB, Smith MD, West PJ, White HS, Wilcox KS.
Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler's virus model of temporal lobe epilepsy.
Neurobiol Dis. 2014 Apr;64:98-106. doi: 10.1016/j.nbd.2013.12.015. Epub 2014 Jan 9.


Jequier Gygax M, Klein BD, White HS, Kim M, Galanopoulou AS.
Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms.
Epilepsy Res. 2014 Jan;108(1):98-108. doi: 10.1016/j.eplepsyres.2013.10.015. Epub 2013 Oct 28.